Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Mylan Speciality drug TOBI PODHALER ap…
New patent expiration for Mylan Speciality drug TOBI PODHALER Read Post »
TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 9,421,166 Expiration: Dec 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations fo…
Drug Patent Expirations for the Week of December 18, 2022 Read Post »
TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 9,421,166 Expiration: Dec 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations fo…
Drug Patent Expirations for the Week of December 18, 2022 Read Post »
Annual Drug Patent Expirations for ZIOPTAN Zioptan is a drug marketed by Thea Pharma and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Thea Pharma drug ZIOPTAN appeared first on …
New patent expiration for Thea Pharma drug ZIOPTAN Read Post »
Annual Drug Patent Expirations for VARUBI Varubi is a drug marketed by Tersera and is included in two NDAs. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Tersera drug VARUBI appeared first on D…
Annual Drug Patent Expirations for VARUBI Varubi is a drug marketed by Tersera and is included in two NDAs. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Tersera drug VARUBI appeared first on D…
Annual Drug Patent Expirations for DORYX Doryx is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma and, and is included in three NDAs. It is available…
The post New patent expiration for Mayne Pharma drug DORYX appeared first on …
New patent expiration for Mayne Pharma drug DORYX Read Post »
Annual Drug Patent Expirations for DORYX Doryx is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma and, and is included in three NDAs. It is available…
The post New patent expiration for Mayne Pharma drug DORYX appeared first on …
New patent expiration for Mayne Pharma drug DORYX Read Post »
Annual Drug Patent Expirations for DORYX+MPC Doryx Mpc is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are five…
The post New patent expiration for Mayne Pharma drug DORYX MPC appeared first on D…
New patent expiration for Mayne Pharma drug DORYX MPC Read Post »
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Vanda Pharms drug HETLIOZ LQ appeared first on …
New patent expiration for Vanda Pharms drug HETLIOZ LQ Read Post »